RecruitingNCT06076005

Characteristics of Advanced LUNG CANCER at the tIme of Diagnosis in a Large Italian Cohor

Demographic, Clinical, Histological and Molecular Characteristics of Advanced LUNG CANCER at the tIme of Diagnosis in a Large Italian Cohort, an Observational Cohort Study: Lung Cancer ID Study

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment

1,000 participants

Start Date

Nov 1, 2023

Study Type

OBSERVATIONAL

Conditions

Lung Cancer Stage IV

Summary

The distribution of demographic, clinical, radiological, pathological and molecular characteristics of lung cancer at the time of diagnosis, as well as preferential association between elements of those domains, have not been specifically studied in Italy. The aim of the present project is to assess, in a systematic fashion, the demographic, clinical, radiological, pathological and molecular characteristics of advanced lung cancer at the time of diagnosis in a large Italian cohort of consecutive patients referred to two tertiary referral centers.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This Italian study is building a large registry of patients newly diagnosed with advanced lung cancer to better understand their characteristics, treatment patterns, and outcomes at the time of diagnosis. **You may be eligible if...** - You are over 18 years old - Imaging tests (CT scan or PET/CT) suggest you may have lung cancer - You are scheduled to have a biopsy to confirm diagnosis, determine staging, or test for molecular markers **You may NOT be eligible if...** - You are unable or unwilling to give written consent - Your health is very poor (ECOG performance status greater than 3), meaning you are largely or completely unable to care for yourself - You have already received a confirmed lung cancer diagnosis (this study focuses on new diagnoses) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERAdvanced lung cancer patients' group

Evaluation of the demographic, clinical, histological and molecular characteristics of advanced lung cancer at the time of Diagnosis

Locations(3)

Interventional Pulmonology Division - Fondazione Policlinico Universitario A. Gemelli IRCCS

Roma, Italy

Istituto Nazionale Tumori Regina Elena

Roma, Italy

Medical Oncology Division - Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Roma, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06076005

Related Trials

The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung Cancer

NCT060003581 location